Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL21239998 | 0.76 | ALDH1A1 (0.36) | LMNASLC6A6CYP2C19BLMAPP | |
| SCHEMBL2759440 | 0.76 | ALDH1A1 (0.36) | ALDH1A1L3MBTL1 | |
| SCHEMBL28620962 | 0.76 | ALDH1A1 (0.36) | ALDH1A1L3MBTL1 | |
| Trifluoromethanesulfonic Acid SCHEMBL28056248 | 0.75 | BLM (0.43) | LMNASLC6A6CYP2C19BLMAPP | |
| SCHEMBL3871127 | 0.74 | LPAR1 (0.35) | ALDH1A1L3MBTL1FDPS | |
| SCHEMBL28621293 | 0.74 | ALDH1A1 (0.35) | ALDH1A1L3MBTL1 | |
| Ammonia Solution, Strong SCHEMBL28620997 | 0.74 | ALDH1A1 (0.35) | ALDH1A1L3MBTL1 | |
| Dimethylamine SCHEMBL18008050 | 0.73 | EPHX1 (0.35) | ALDH1A1L3MBTL1 | |
| Dimethylamine SCHEMBL28635368 | 0.73 | ALDH1A1 (0.31) | ALDH1A1L3MBTL1 | |
| SCHEMBL5031182 | 0.72 | PTGS1 (0.36) | ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100311860-A1 | METHOD FOR MAKING PROTON CONDUCTING MEMBRANES FOR FUEL CELLS BY RADIOGRAFTING | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2010-12-09 | — | — | US | disclosed |
| US-20100311860-A1 | METHOD FOR MAKING PROTON CONDUCTING MEMBRANES FOR FUEL CELLS BY RADIOGRAFTING | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2010-12-09 | — | — | US | disclosed |
| US-20100304273-A1 | PROTON CONDUCTING MEMBRANES FOR FUEL CELLS HAVING A PROTON GRADIENT AND METHODS FOR PREPARING SAID MEMBRANES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2010-12-02 | — | — | US | disclosed |
| US-20100304273-A1 | PROTON CONDUCTING MEMBRANES FOR FUEL CELLS HAVING A PROTON GRADIENT AND METHODS FOR PREPARING SAID MEMBRANES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2010-12-02 | — | — | US | disclosed |
| WO-2009040362-A1 | PROTON CONDUCTING MEMBRANES FOR FUEL CELLS HAVING A PROTON GRADIENT AND METHOD FOR PREPARING SAID MEMBRANES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009040365-A1 | METHOD FOR MAKING PROTON CONDUCTING MEMBRANES FOR FUEL CELLS BY RADIOGRAFTING | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2009-04-02 | — | — | WO | disclosed |
| EP-1828111-A2 | METHODS AND FLUORINATED COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | Neurochem (International) Limited (CH) | 2007-09-05 | — | — | EP | disclosed |
| US-20060183800-A1 | Methods and fluorinated compositions for treating amyloid-related diseases | BELLUS HEALTH (INTERNATIONAL) LIMITED (CH) | 2006-08-17 | — | — | US | disclosed |
| WO-2006059252-A2 | METHODS AND FLUORINATED COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2006-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060183800-A1 | Methods and fluorinated compositions for treating amyloid-related diseases | APP, PSEN1, TTR | LMNA 50/4885SLC6A6 2124/4885CYP2C19 1055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.